Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

A calcium transport mechanism for atrial fibrillation in Tbx5-mutant mice.

Wenli Dai | Brigitte Laforest | Leonid Tyan | Kaitlyn M Shen | Rangarajan D Nadadur | Francisco J Alvarado | Stefan R Mazurek | Sonja Lazarevic | Margaret Gadek | Yitang Wang | Ye Li | Hector H Valdivia | Le Shen | Michael T Broman | Ivan P Moskowitz | Christopher R Weber
eLife | 2019

Risk for Atrial Fibrillation (AF), the most common human arrhythmia, has a major genetic component. The T-box transcription factor TBX5 influences human AF risk, and adult-specific Tbx5-mutant mice demonstrate spontaneous AF. We report that TBX5 is critical for cellular Ca2+ homeostasis, providing a molecular mechanism underlying the genetic implication of TBX5 in AF. We show that cardiomyocyte action potential (AP) abnormalities in Tbx5-deficient atrial cardiomyocytes are caused by a decreased sarcoplasmic reticulum (SR) Ca2+ ATPase (SERCA2)-mediated SR calcium uptake which was balanced by enhanced trans-sarcolemmal calcium fluxes (calcium current and sodium/calcium exchanger), providing mechanisms for triggered activity. The AP defects, cardiomyocyte ectopy, and AF caused by TBX5 deficiency were rescued by phospholamban removal, which normalized SERCA function. These results directly link transcriptional control of SERCA2 activity, depressed SR Ca2+ sequestration, enhanced trans-sarcolemmal calcium fluxes, and AF, establishing a mechanism underlying the genetic basis for a Ca2+-dependent pathway for AF risk.

Pubmed ID: 30896405

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL134344
  • Agency: NHLBI NIH HHS, United States
    Id: R37 HL026057
  • Agency: American Heart Association, International
    Id: Collaborative Sciences Award
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL108175
  • Agency: NIH HHS, United States
    Id: T32HL007381
  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL007381
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL026057
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL055438
  • Agency: NIBIB NIH HHS, United States
    Id: T32 EB009412
  • Agency: NIH HHS, United States
    Id: HL126509
  • Agency: NHLBI NIH HHS, United States
    Id: R33 HL123857
  • Agency: NIH HHS, United States
    Id: R33 HL123857
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL126509
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL114010
  • Agency: NICHD NIH HHS, United States
    Id: T32 HD055164
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007281
  • Agency: NIH HHS, United States
    Id: HL114010
  • Agency: NIH HHS, United States
    Id: T32GM007281

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Millipore (tool)

RRID:SCR_008983

An Antibody supplier

View all literature mentions

MP Biomedicals (tool)

RRID:SCR_013308

An Antibody supplier

View all literature mentions